Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 52: 488-493, 2006. First published December 29, 2005; 10.1373/clinchem.2005.060152
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
clinchem.2005.060152v1
52/3/488    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martens-Lobenhoffer, J.
Right arrow Articles by Bode-Böger, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martens-Lobenhoffer, J.
Right arrow Articles by Bode-Böger, S. M.
Related Collections
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2006;52:488-493.)
© 2006 American Association for Clinical Chemistry, Inc.

Automation and Analytical Techniques

Fast and Efficient Determination of Arginine, Symmetric Dimethylarginine, and Asymmetric Dimethylarginine in Biological Fluids by Hydrophilic-Interaction Liquid Chromatography–Electrospray Tandem Mass Spectrometry

Jens Martens-Lobenhoffera and Stefanie M. Bode-Böger

Institute of Clinical Pharmacology, Otto-von-Guericke-University Magdeburg, University Hospital, Magdeburg, Germany.

aAddress correspondence to this author at: Otto-von-Guericke-Universität, Institut für Klinische Pharmakologie, Leipziger Strasse 44, D-39120 Magdeburg, Germany. Fax 49-391-67-13062; e-mail jens.martens-lobenhoffer{at}medizin.uni-magdeburg.de.

Background: Nitric oxide is synthesized from the amino acid Arg by the enzyme endothelial nitric oxide synthase, which is competitively inhibited by the arginine metabolite asymmetric dimethylarginine (ADMA). In this way, increased concentrations of ADMA lead to reduced nitric oxide production associated with a range of cardiac diseases. Research in this field requires the measurement of Arg and of ADMA and its closely related substance, symmetric dimethylarginine (SDMA).

Methods: We quantified Arg, ADMA, and SDMA in human plasma, human urine, and cell culture supernatant by HPLC–electrospray tandem mass spectrometry. Sample preparation required only protein precipitation. Separation was by liquid chromatography on a 150 x 3 mm silica column with an isocratic mobile phase consisting of water–acetonitrile–trifluoroacetic acid–propionic acid (10:90:0.025:1 by volume). The chromatographic run time was 7 min.

Results: The chromatograms were interference-free in all matrices. In the low-concentration quality-control samples, the interassay CVs in plasma were 4.7% for Arg, 7.7% for ADMA, and 4.9% for SDMA. Similar values were obtained in urine and cell culture supernatants. The calibration functions were linear and covered the ranges of healthy and pathologic samples.

Conclusion: The new method requires neither derivatization nor complete chromatographic separation between ADMA and SDMA for quantification of the 3 metabolites, has calibration functions that are independent of the sample matrix, and provides measured concentrations that agree with those reported in the literature.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Association for Clinical Chemistry.